2 completed, 2 recruiting, 1 not yet recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Not yet recruiting 1 |
Follow Overactive Bladder (OAB): new trials by email Literature Review of Overactive Bladder (OAB) trials Research Report on Overactive Bladder (OAB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder NT 201 200U and Vibe System, NT 201 300U and Vibe System, Placebo and sham - Overactive Bladder (OAB) | Phase 2 | Recruiting | Vensica Therapeutics Ltd. | 210 | 2026-08-14 | 2026-10-16 |
| Zinc Supplementation With Botulinum Toxin for Overactive Bladder Zinc Citrate Oral Capsule, Placebo - Overactive Bladder (OAB) | Phase 2 | Recruiting | Endeavor Health | 72 | 2026-02-26 | 2026-07-02 |
| Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder. TRG-200 KIT - Overactive Bladder (OAB) | Phase 2 | Not yet recruiting | Trigone Pharma Ltd. | 60 | 2026-02-15 | 2026-02-06 |
| SVT-40776 in Patients Suffering From Overactive Bladder Syndrome SVT-40776 - Overactive Bladder (OAB) | Phase 2 | Completed | Salvat | 2006-09-01 | 2011-06-08 | |
| A Phase II Study of KUC-7483 in Patients With Overactive Bladder KUC-7483, Placebo - Overactive Bladder (OAB) | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 400 | 2009-09-04 |
Urinary Bladder, Overactive (5) · Urinary Incontinence, Urge (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Lower Urinary Tract Symptoms (5) · Male Urogenital Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Urinary Bladder Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Urological Manifestations (5) · Urinary Incontinence (1) · Urination Disorders (1)
SVT-40776 (1) · incobotulinumtoxinA (1) · ritobegron ethyl (1) · salicylhydroxamic acid (1)
Endeavor Health (1) · Kissei Pharmaceutical Co., Ltd. (1) · Salvat (1) · Trigone Pharma Ltd. (1) · Vensica Therapeutics Ltd. (1)
United States (2) · Israel (1) · Japan (1)
Ghazaleh Rostami Nia, MD (1) · Yasuhiro Omori (1)